Pollock, C. ., Sanchez, J. J. G., Carrero, J. J., Kumar, S. ., Pecoits-Filho, R. ., Lam, C. S. P., … Wheeler, D. C. (2023). Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification. Diabet Med, e15200. http://doi.org/10.1111/dme.15200
H. Chen
First name
H.
Last name
Chen
Johannes, C. B., Beachler, D. C., Layton, J. B., Danysh, H. E., Ziemiecki, R. ., Arana, A. ., … Gilsenan, A. . (2022). Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Saf. http://doi.org/10.1007/s40264-022-01263-3
Danysh, H. E., Johannes, C. B., Beachler, D. C., Layton, J. B., Ziemiecki, R. ., Arana, A. ., … Gilsenan, A. . (2022). Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Saf. http://doi.org/10.1007/s40264-022-01262-4
James, G. ., Sanchez, J. J. G., Carrero, J. J., Kumar, S. ., Pecoits-Filho, R. ., Heerspink, H. J. L., … Wheeler, D. C. (2022). Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility. Kidney Int Rep, 7, 2059–2070. http://doi.org/10.1016/j.ekir.2022.05.033
Mehta, H. B., Mehta, V. ., Tsai, C. L., Chen, H. ., Aparasu, R. R., & Johnson, M. L. (2016). Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension. J Alzheimers Dis. http://doi.org/10.3233/jad-150466
Cherney, D. Z. I., Repetto, E. ., Wheeler, D. C., Arnold, S. V., MacLachlan, S. ., Hunt, P. R., … Kosiborod, M. . (2019). Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus. Am J Nephrol. http://doi.org/10.1159/000504558